Skip to content

Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02817321
Enrollment
76
Registered
2016-06-29
Start date
2016-11-30
Completion date
2018-11-30
Last updated
2019-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Hepatectomy, Nerve Block

Brief summary

This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al. single-injection TPVB +continuous(pulsatile infusion) TPVB and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

Interventions

PROCEDUREsingle-injection TPVB + continuous TPVB

Inject local anesthetics in the T8 paravertebral space followed with catheter insertion and continuous local infusion.

The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scanning

* 2mg/kg ropivacaine in saline with 1:200,000 adrenaline, 25ml in total * given immediately after the correct position of the tip of the needle has been confirmed

DRUGcontinuously infusion of ropivacaine

* 0.2% ropivacaine, pulse dosadge: 0.125ml/kg/pulse, 1pulse/h at a rate of 6ml/minutes * given through the catheter inserted in the T8 paravertebral space following the single dose

bolus: 2mg, lock time: 10min, 1h limitation: 8mg

Sponsors

Cui Xulei
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-70 yrs * American Society of Anesthesiologists physical statusⅠ-Ⅲ * Undergo hepatectomy with J-shape subcostal incision * Informed consent

Exclusion criteria

* A known allergy to the drugs being used * Coagulopathy, on anticoagulants * Analgesics intake, history of substance abuse * Participating in the investigation of another experimental agent * Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

Design outcomes

Primary

MeasureTime frame
cumulative morphine consumptionwithin 48 postoperative hours

Secondary

MeasureTime frameDescription
nausea and vomiting scoreAt 0, 2,4, 8, 12, 24 and 48hours after the surgery
pruritus scoreAt 0, 2,4, 8, 12, 24 and 48hours after the surgery
ambulation timewithin the 7 days after surgery
The pain scores determined by the numeric rating scale (NRS, 0-10)At 0, 2,4, 8, 12, 24 ,48,72hours and 7day after the surgery
Postoperative hospital length of stayUp to 4 weeks
patient satisfaction with anesthesia48 hours after surgeryuse the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia
data collection of chronic painat 3,6,12 months after surgeryPatients undergo a telephone interview with a questionnaire at 3, 6 and 12 months after surgery, the incidence and severity of chronic pain is recorded.
time of recovery of bowl movementwithin the 7 days after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026